IP Library Granted Patent US 8,777,987
Granted Patent B2
US 8,777,987 · App. 12/680,176 · Granted Jul 15, 2014

Self-retaining sutures including tissue retainers having improved strength

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,777,987
App. No.
12/680,176
Granted
Jul 15, 2014
Kind
B2
Abstract

An embodiment of a suture for use in a surgical procedure applied to tissue comprises an elongated body having a first end and a second end, and a plurality of retainers arranged along a portion of the elongated body. The retainers substantially yield to motion of the elongated body within the tissue when the elongated body is drawn at the first end and resist motion of the elongated within the tissue when the elongated body is drawn at the second end. The retainers include an upper surface and a lower surface, the upper surface extending from a periphery of the elongated body and the lower surface having at least two facets.

Claims (28)

1. A suture for use in a procedure applied to tissue comprising:

an elongated body having a first end and a second end; and

a plurality of retainers arranged along a portion of the elongated body, each retainer being formed by a cut into the elongated body and each retainer having a tissue penetrating end;

wherein the retainers substantially yield to motion of the elongated body within the tissue when the elongated body is drawn in a first direction and resist motion of the elongated body within the tissue when the elongated body is drawn in a second direction opposite the first direction; and

wherein the retainers include an exterior surface and an interior surface, the exterior surface extending from a periphery of the elongated body and the interior surface being formed by said cut, and the interior surface having at least two facets;

wherein at least two of the at least two facets converge to form a line, the line running in the same direction as the first direction; and

wherein the cut terminates at an apex located within the outer dimension of the elongated body as defined by locations in which no cut is present.

2. The suture of claim 1 , wherein one or both of the elongated body and the plurality of retainers includes an associated material to be delivered to the tissue.

3. The suture of claim 2 , wherein the associated material is one or more of a hormone, a drug, and medicine.

4. The suture of claim 1 , wherein the plurality of retainers is a first set and the portion of the elongated body is a first portion; and further comprising:

a second set including a plurality of retainers each formed by a cut into the elongated body, the retainers being arranged along a second portion of the elongated body;

wherein the retainers of the second set substantially yield to motion of the elongated body within the tissue when the elongated body is drawn at the second end and resist motion of the elongated within the tissue when the elongated body is drawn at the first end; and

wherein the retainers of the second set include an exterior surface and interior surface, and a tissue penetrating end, the exterior surface extending from a periphery of the elongated body and the interior surface being formed by said cut, and the interior surface having at least two facets, and the cut terminates at an apex located within the outer dimension of the elongated body as defined by locations in which no cut is present.

5. The suture of claim 4 wherein the interior surface of the first set has exactly two facets.

6. The suture of claim 4 wherein the interior surface of the first set has exactly three facets.

7. The suture of claim 1 , wherein the interior surface is one of V-shaped, rectangular-shaped, and trapezoidal-shaped.

8. The suture of claim 1 wherein the interior surface has exactly two facets.

9. The suture of claim 1 wherein the interior surface has exactly three facets.

10. A suture for use in a procedure applied to tissue comprising:

an elongated body having a longitudinal axis, a first end and a second end; and

a plurality of retainers arranged along a portion of the elongated body, each retainer being formed by a cut into the elongated body and each retainer having a tissue penetrating end;

wherein the retainers substantially yield to motion of the elongated body within the tissue when the elongated body is drawn in a first direction and resist motion of the elongated body within the tissue when the elongated body is drawn in a second direction opposite the first direction; and

wherein the retainers include an exterior surface and an interior surface, the exterior surface extending from a periphery of the elongated body and the interior surface being formed by said cut, and the interior surface having at least two facets;

wherein the at least two facets converge along a line, the line being parallel to the longitudinal axis of the elongated body; and

wherein the cut terminates at an apex located within the outer dimension of the elongated body as defined by locations in which no cut is present.

11. The suture of claim 10 , wherein the interior surface is one of V-shaped, rectangular-shaped, and trapezoidal-shaped.

12. The suture of claim 10 wherein the interior surface has exactly two facets.

13. The suture of claim 10 wherein the interior surface has exactly three facets.

Assignments (11)
RELEASE OF SECURITY INTEREST : RECORDED AT REEL/FRAME - 049288/0184 Recorded Jan 29, 2021
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 055171/0634 →
SECURITY INTEREST Recorded May 26, 2019
From: ANGIOTECH PHARMACEUTICALS, INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049288/0184 →
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2013
From: WELLS FARGO CAPITAL FINANCE, LLC
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030211/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2012
From: ANGIOTECH PHARMACEUTICALS, INC.; QUILL MEDICAL, INC.
To: ETHICON, INC.; ETHICON, LLC
Reel/Frame 029294/0443 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded May 16, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028216/0499 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded Apr 20, 2012
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028078/0699 →
PARTIAL RELEASE OF SECURITY INTEREST - PATENTS Recorded Apr 10, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028022/0861 →
PATENT SECURITY AGREEMENT Recorded May 13, 2011
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH DELAWARE, INC.; ANGIOTECH FLORIDA HOLDINGS, INC.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 BRITISH COLUMBIA LTD.; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.
To: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 026275/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2010
From: HERRMANN, ROBERT A.; GORALTCHOUK, ALEXEI; DRUBETSKY, LEV
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 025128/0128 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2010
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDIA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALITIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 024861/0219 →
SECURITY AGREEMENT Recorded May 24, 2010
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 024431/0804 →